Biotechnology Ultrasector Financial Statements From 2010 to 2024
| BIPIX Fund | USD 65.12 1.96 3.10% |
Check Biotechnology Ultrasector financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotechnology Ultrasector's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biotechnology financial statements analysis is a perfect complement when working with Biotechnology Ultrasector Valuation or Volatility modules.
Biotechnology |
Biotechnology Ultrasector Profund Mutual Fund Year To Date Return Analysis
Biotechnology Ultrasector's Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
More About Year To Date Return | All Equity Analysis
YTD Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Current Biotechnology Ultrasector Year To Date Return | 17.99 % |
Most of Biotechnology Ultrasector's fundamental indicators, such as Year To Date Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Ultrasector Profund is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Year-To-Date typically refers to a period starting from the beginning of the current year and continuing up to the present day. Investors should becareful when comparing YTD ratios if not much of the year has occurred as research shows that YTD measures are more sensitive to early periods than late.
| Competition |
In accordance with the company's disclosures, Biotechnology Ultrasector Profund has a Year To Date Return of 17.9948%. This is much higher than that of the ProFunds family and significantly higher than that of the Trading--Leveraged Equity category. The year to date return for all United States funds is notably lower than that of the firm.
Biotechnology Ultrasector Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Ultrasector's current stock value. Our valuation model uses many indicators to compare Biotechnology Ultrasector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Ultrasector competition to find correlations between indicators driving Biotechnology Ultrasector's intrinsic value. More Info.Biotechnology Ultrasector Profund is fourth largest fund in price to earning among similar funds. It is the top fund in price to book among similar funds fabricating about 2.19 of Price To Book per Price To Earning. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Ultrasector's earnings, one of the primary drivers of an investment's value.About Biotechnology Ultrasector Financial Statements
Biotechnology Ultrasector investors use historical fundamental indicators, such as Biotechnology Ultrasector's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotechnology Ultrasector. Please read more on our technical analysis and fundamental analysis pages.
The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the SP Total Market Index, which comprises the following sub-industry biotechnology. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Ultrasector financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Ultrasector security.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |